The HHS issues more details on President Donald Trump's plans to lower U.S. drug prices through most-favored-nation drug ...

A new report concludes that mental health apps like Rejoyn and DaylightRx can save money and improve outcomes.

Investors and consultants in the space said that they have seen rising enthusiasm among investors as recent funding rounds outpace prior hauls.

If the initiative proceeds as planned, it will mark a pivotal shift in the regulatory landscape, introducing both efficiencies and novel ...

AI adoption in the corporate world is not a sprint—it’s a strategic journey where early experimentation gives way to ...

The FDA and NIH recently announced plans to phase out animal testing requirements for some therapies. While organoid and AI ...

The department’s chief data and artificial intelligence office and members of the Data & AI Board will oversee the new center.

The Administration for Strategic Preparedness and Response May 15 announced it is launching four pharmaceutical manufacturing ...

AI-powered tools are enhancing precision, efficiency, and decision-making in biopharmaceutical development. Recently, Jared ...

The rollout will allow FDA scientists and subject-matter experts to spend less time on ‘tedious, repetitive tasks,’ the ...

Lantern Pharma's Q1 2025 earnings reveal clinical progress, AI commercialization plans, and financial discipline.